Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Regulatory News (AVO)

  • There is currently no data for AVO

Senior Management Appointment

13 Sep 2006 07:04

CareCapital Group plc13 September 2006 For release at 0700h, 13 September 2006 CareCapital Group Plc ("CareCapital" or "the Group") Senior Management Appointment CareCapital (AIM: CARE), a healthcare real estate developer and owner that wasadmitted to AIM on 4 August 2006, today announces that Louise Matthews has beenappointed to the senior management team as Director - Healthcare Projects. Shewill be responsible for all projects subject to public procurement processesfrom initial submissions through to the hand-over of completed developments totenants. Louise has considerable previous experience in both healthcare and projectmanagement, most recently gained as Healthcare Projects Manager with LaingO'Rourke, Portfolio Solutions, where she was responsible for identifying andprogressing business development opportunities in major health and associatedprojects including ProCure21, LIFT and PFI. Prior to Laing O'Rourke, Louise spent her career, starting in 1985, in a numberof increasingly senior positions with NHS Trusts in the Birmingham area. From1994-1997, she was Chief Internal Auditor and Head of Specialist Services withHealthcare Audit Services (an NHS Agency). She went on to hold two seniorpositions at NHS Trusts: Trust Board Secretary and Capital & PFI Audit Manager,South Birmingham Mental Health NHS Trust and Risk and Legal Manager, NewHospitals Project, University of Birmingham NHS Trust. Louise holds an MSc in Construction Management and is a Fellow of the Instituteof Internal Auditors. Paul Stacey, CareCapital's Managing Director, commented, "We are delighted thatLouise has agreed to join us. Her NHS and construction industry experience willsignificantly enhance the capabilities and skill sets within the CareCapitalteam as we seek to grow the business. Her appointment is really excellent newsfor the Company." For further information please visit www.carecapital.co.uk or contact: Paul Stacey, Managing Director Shareen Courtney, MarketingCareCapital Group PlcTel: 020 7034 1949pstacey@carecapital.co.ukscourtney@carecapital.co.uk Simon Hudson, Richard SunderlandTavistock CommunicationsTel: 020 7920 3150shudson@tavistock.co.ukrsunderland@tavistock.co.uk Lindsay Mair, Director - Corporate FinanceDaniel Stewart & Co PlcTel: 020 7776 6550lindsay.mair@danielstewart.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th May 20247:00 amRNSCancellation - Advanced Oncotherapy Plc
3rd May 20248:54 amRNSFurther update on financing discussions
2nd Apr 20243:50 pmRNSFurther update on financing discussions
29th Feb 20245:19 pmRNSFurther update on financing discussions
1st Feb 20247:00 amRNSFurther update on financing discussions
9th Jan 20249:00 amRNSUpdate on Financing Discussions
23rd Oct 20237:00 amRNSUpdate on Financing and Current Financial Position
17th Jul 20237:00 amRNSRecapitalisation and funding plan, update on FSP
30th Jun 20235:00 pmRNSTotal Voting Rights
30th Jun 20237:30 amRNSSuspension - Advanced Oncotherapy PLC
30th Jun 20237:15 amRNSUpdate on financing, suspension of trading on AIM
29th Jun 20231:35 pmRNSHolding(s) in Company
29th Jun 20239:59 amRNSForm 8.3 - Advanced Oncotherapy PLC
28th Jun 202310:25 amRNSForm 8.3 - Advanced Oncotherapy PLC
27th Jun 202310:29 amRNSForm 8.3 - Advanced Oncotherapy
27th Jun 202310:25 amRNSForm 8.3 - Advanced Oncotherapy
26th Jun 20234:26 pmRNSForm 8.3 - Advanced Oncotherapy
26th Jun 202310:57 amRNSPartial conversion of Convertible Notes
23rd Jun 202311:05 amRNSHolding(s) in Company
23rd Jun 20239:30 amRNSForm 8.3 - Advanced Oncotherapy PLC
20th Jun 20235:28 pmRNSHolding(s) in Company
19th Jun 20235:56 pmRNSPartial conversion of Convertible Notes
19th Jun 20231:48 pmRNSForm 8.3 - Advanced Oncotherapy PLC
16th Jun 20236:23 pmRNSIssue of warrants
13th Jun 202311:46 amRNSForm 8.3 - Advanced Oncotherapy PLC
31st May 20235:57 pmRNSUpdate on financing and convertible notes
30th May 202310:42 amRNSForm 8.3 - Advanced Oncotherapy Plc
24th May 20235:54 pmRNSForm 8 (OPD) Advanced Oncotherapy plc
24th May 20235:29 pmRNSForm 8.3 - Advanced Oncotherapy - Cosylab d.d.
22nd May 20232:59 pmRNSForm 8.3 - Advanced Oncotherapy plc
19th May 202312:09 pmRNSForm 8.3 - Advanced Oncotherapy PLC
17th May 20232:58 pmRNSForm 8.3 - Advanced Oncotherapy plc
15th May 202311:36 amRNSUpdate on Convertible Note & Loan Extension
15th May 20239:19 amRNSForm 8.3 - Advanced Oncotherapy Plc
12th May 202312:53 pmRNSForm 8.3 - Advanced Oncotherapy - Minmetco Limited
11th May 20235:14 pmRNSForm 8.3 - Advanced Oncotherapy - eQ Blue Planet
11th May 202311:17 amRNSForm 8.3 - Advanced Oncotherapy - Atlantic Cedar
10th May 202311:34 amRNSForm 8.3 - Advanced Oncotherapy plc
9th May 20234:40 pmRNSForm 8.3 - Advanced Oncotherapy - Baltisches Haus
9th May 20234:37 pmRNSForm 8.3 - Advanced Oncotherapy plc
9th May 20234:36 pmRNSForm 8.3 - Advanced Oncotherapy plc
5th May 20238:56 amRNSFORM 8.3 - Advanced Oncotherapy
5th May 20237:00 amRNSAdditional funding from Secured Convertible Note
4th May 20235:01 pmRNSForm 8.3 - Advanced Oncotherapy Plc
4th May 20233:55 pmRNSChange of Registered Office
3rd May 20236:19 pmRNSRule 2.9 Announcement
3rd May 20234:28 pmRNSForm 8.3 - Advanced Oncotherapy PLC
2nd May 20236:19 pmRNSForm 8 (OPD) Advanced Oncotherapy plc
18th Apr 20237:00 amRNSStrategic review and formal sale process
31st Mar 20236:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.